Adapting the DOTS Framework for Tuberculosis Control to the Management of Non-Communicable Diseases in Sub-Saharan Africa
article has not abstract
Vyšlo v časopise:
Adapting the DOTS Framework for Tuberculosis Control to the Management of Non-Communicable Diseases in Sub-Saharan Africa. PLoS Med 5(6): e124. doi:10.1371/journal.pmed.0050124
Kategorie:
Health in Action
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.0050124
Souhrn
article has not abstract
Zdroje
1. BainganaFKBosER
2006
Changing patterns of disease and mortality in sub-Saharan Africa: An overview.
In
JamisonDTFeachemRGMakgobaMWBosERBainganaFK
editors
Disease and mortality in sub-Saharan Africa
Second Edition
World Bank
1
9
2. LopezADMathersCDEzzatiMJamisonDTMurrayCJL
2006
Global Burden of Disease and risk factors
The World Bank and Oxford University Press
Available: http://www.dcp2.org/pubs/GBD. Accessed 1 May 2008
3. MurrayCLopezA
1996
The Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020, Volume 1
Geneva
World Health Organization
Available: http://www.hsph.harvard.edu/organizations/bdu/GBDseries.html. Accessed 2 May 2008
4. YudkinJS
1999
Tanzania: Still optimistic after all these years.
Lancet
353
1519
1521
5. HortonR
2001
Ghana: Defining the African challenge.
Lancet
358
2141
2149
6. HargreavesS
2002
Time to right the wrongs: Improving basic health care in Nigeria.
Lancet
359
2030
2035
7. WalkerRWMcLartyDGKitangeHMWhitingDMasukiG
2000
Stroke mortality in urban and rural Tanzania.
Lancet
355
1684
1687
8. ThorogoodMConnorMDLewando-HundtGTollmanSNgomaB
2004
Secondary prevention of stroke—Results from the Southern Africa Stroke Prevention Initiative (SASPI) study.
Bull World Health Organ
82
503
508
9. ConnorMDThorogoodMCasserlyBDobsonCWarlowCP
2004
Prevalence of stroke survivors in rural South Africa. Results from the Southern Africa Stroke Prevention Initiative (SASPI) Agincourt field site.
Stroke
35
627
632
10. ShorvonSDFarmerP
1988
Epilepsy in developing countries.
Epilepsia
29
S36
S54
11. Ait-KhaledNEnarsonDABencharifNBoulahdibFCamaraLM
2006
Implementation of asthma guidelines in health centres of several developing countries.
Int J Tuberc Lung Dis
10
104
109
12. Ait-KhaledNAureganGBencharifNCamaraLMDagliE
2000
Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries.
Int J Tuberc Lung Dis
4
268
271
13. BeranDYudkinJS
2006
Diabetes care in sub-Saharan Africa.
Lancet
368
1689
1695
14. WilkinsonDWilkinsonNF
2004
Organization of non-communicable disease care.
In
ParryEGodfreyRMabeyDGillG
editors
Principles of medicine in Africa
Third edition
Cambridge
Cambridge University Press
828
834
15. EnarsonDA
1991
Principles of IUATLD collaborative tuberculosis programmes.
Bull Int Union Tuberc Lung Dis
66
195
200
16. World Health Organization
1994
WHO Tuberculosis Programme. Framework for effective tuberculosis control. WHO/TB/94.179
Geneva
World Health Organization
17. World Health Organization
2007
Global tuberculosis control—Surveillance, planning, financing.
Available: http://www.who.int/tb/publications/global_report/en/. Accessed 2 May 2008
18. HarriesADNyanguluDSHargreavesNJKaluwaOSalaniponiFM
2001
Preventing antiretroviral anarchy in sub-Saharan Africa.
Lancet
357
1519
1523
19. LibambaEMakombeSHarriesADChimziziRSalaniponiFM
2005
Scaling up antiretroviral therapy in Africa: Learning from tuberculosis control programmes—The case of Malawi.
Int J Tuberc Lung Dis
9
1062
1071
20. HarriesADSchoutenEJLibambaE
2006
Scaling up antiretroviral therapy in resource-poor settings.
Lancet
367
1870
1872
21. Malawi Ministry of Health
2006
Treatment of AIDS. Guidelines for the use of antiretroviral therapy in Malawi
Second edition
Lilongwe
Malawi Ministry of Health
22. LibambaEMakombeSMhangoEde Ascurra TeckOLimbambalaE
2006
Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi.
Bull World Health Organ
84
320
326
23. YachDHawkesCGouldCLHofmanKJ
2004
The global burden of chronic diseases. Overcoming impediments to prevention and control.
JAMA
291
2616
2622
24. HarriesADSchoutenEJMakombeSDLibambaENeufvilleH
2007
Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: An example from Malawi.
Bull World Health Organ
85
156
160
25. PatelVFarooqSTharaR
2007
What is the best approach to treating schizophrenia in developing countries.
PLoS Med
4
e159
doi:10.1371/journal.pmed.0040159
26. El SonyASlamaKSaliehMElhajHAdamK
2007
Feasibility of brief tobacco cessation advice for tuberculosis patients: A study from Sudan.
Int J Tuberc Lung Dis
11
150
155
27. YuJKChenSCWangKYChangC-SMakombeSD
2007
True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi.
Bull World Health Organ
85
550
554
28. UnwinNSetelPRashidSMugusiFMbanyaJC
2001
Noncommunicable diseases in sub-Saharan Africa: Where do they feature in the health research agenda.
Bull World Health Organ
79
947
953
29. DaarASSingerPAPersadDLPrammingSKMatthewsDR
2007
Grand challenges in chronic non-communicable diseases.
Nature
450
494
496
30. FriedenTR
2004
Asleep at the switch: Local public health and chronic disease.
Am J Pub Health
94
2059
2061
31. RamaiyaK
2005
Tanzania and diabetes—A model for developing countries.
BMJ
330
679
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2008 Číslo 6
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
Najčítanejšie v tomto čísle
- Ethical Implications of Modifying Lethal Injection Protocols
- Subnational Burden of Disease Studies: Mexico Leads the Way
- Guidelines for Reporting Health Research: The EQUATOR Network's Survey of Guideline Authors
- How Might Cocaine Interfere with Brain Development?